E. MENTA

432 total citations
18 papers, 386 citations indexed

About

E. MENTA is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, E. MENTA has authored 18 papers receiving a total of 386 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Organic Chemistry and 5 papers in Oncology. Recurrent topics in E. MENTA's work include Cancer therapeutics and mechanisms (10 papers), Bioactive Compounds and Antitumor Agents (5 papers) and DNA and Nucleic Acid Chemistry (5 papers). E. MENTA is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Bioactive Compounds and Antitumor Agents (5 papers) and DNA and Nucleic Acid Chemistry (5 papers). E. MENTA collaborates with scholars based in Italy, United States and Australia. E. MENTA's co-authors include A. Paul Krapcho, Roberto Di Domenico, H.H. Fiebig, Graziella Pratesi, Franco Zunino, C. Manzotti, Gabriella Pezzoni, Nicholas P. Farrell, Donatella Polizzi and Lloyd R. Kèlland and has published in prestigious journals such as Nucleic Acids Research, Biochemical Pharmacology and Molecular Pharmacology.

In The Last Decade

E. MENTA

18 papers receiving 378 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. MENTA Italy 9 210 187 177 53 35 18 386
Gino Beggiolin United States 10 218 1.0× 192 1.0× 228 1.3× 52 1.0× 64 1.8× 13 435
Homayon J. Arabshahi New Zealand 11 155 0.7× 254 1.4× 221 1.2× 12 0.2× 44 1.3× 17 499
S Tognella Italy 10 154 0.7× 100 0.5× 125 0.7× 83 1.6× 22 0.6× 37 398
Roberto Di Domenico United States 8 192 0.9× 205 1.1× 161 0.9× 14 0.3× 24 0.7× 13 362
Wei-Guo Bao China 13 185 0.9× 121 0.6× 185 1.0× 38 0.7× 4 0.1× 28 414
Tsung‐Chih Chen Taiwan 16 133 0.6× 219 1.2× 328 1.9× 38 0.7× 125 3.6× 27 550
Amalia Cipollone Italy 9 165 0.8× 120 0.6× 236 1.3× 23 0.4× 40 1.1× 15 418
Petr Sova Czechia 17 336 1.6× 143 0.8× 259 1.5× 36 0.7× 9 0.3× 28 537
Dan Berger United States 10 100 0.5× 186 1.0× 191 1.1× 11 0.2× 52 1.5× 12 354
Elin Jerremalm Sweden 9 245 1.2× 86 0.5× 227 1.3× 32 0.6× 9 0.3× 9 513

Countries citing papers authored by E. MENTA

Since Specialization
Citations

This map shows the geographic impact of E. MENTA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. MENTA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. MENTA more than expected).

Fields of papers citing papers by E. MENTA

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. MENTA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. MENTA. The network helps show where E. MENTA may publish in the future.

Co-authorship network of co-authors of E. MENTA

This figure shows the co-authorship network connecting the top 25 collaborators of E. MENTA. A scholar is included among the top collaborators of E. MENTA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. MENTA. E. MENTA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Evison, Benny J., et al.. (2007). Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agent. Nucleic Acids Research. 35(11). 3581–3589. 36 indexed citations
2.
Grams, Frank, Hans Brandstetter, S. D’Alò, et al.. (2001). Pyrimidine-2,4,6-triones: A new effective and selective class of matrix metalloproteinase inhibitors (vol 382, pg 1278, 2001). Biological Chemistry. 382(12). 1739–1739. 2 indexed citations
3.
Sissi, Claudia, Stefano Moro, Sara N. Richter, et al.. (2001). DNA-Interactive Anticancer Aza-Anthrapyrazoles: Biophysical and Biochemical Studies Relevant to the Mechanism of Action. Molecular Pharmacology. 59(1). 96–103. 15 indexed citations
4.
Sissi, Claudia, Stefano Moro, Sara N. Richter, et al.. (2001). DNA-Interactive Anticancer Aza-Anthrapyrazoles: Biophysical and Biochemical Studies Relevant to the Mechanism of Action. Molecular Pharmacology. 59(1). 96–103. 1 indexed citations
5.
Krapcho, A. Paul, et al.. (2000). Synthesis and antitumor activities of 5-methyl-1- and 2-[[2-dimethylaminoethyl]amino]-aza-thiopyranoindazoles. Bioorganic & Medicinal Chemistry Letters. 10(3). 305–308. 9 indexed citations
6.
Manzotti, C., Graziella Pratesi, E. MENTA, et al.. (2000). BBR 3464: a novel triplatinum complex, exhibiting a preclinical profile of antitumor efficacy different from cisplatin.. PubMed. 6(7). 2626–34. 154 indexed citations
7.
Sissi, Claudia, Stefano Moro, Giuseppe Zagotto, et al.. (1999). Binding of bis-substituted 2-aza-anthracenedione regioisomers to DNA: effects of the relative positioning of the side chains.. PubMed. 14(3). 265–74. 2 indexed citations
8.
9.
Blasi, P. Di, et al.. (1998). Cytotoxicity, cellular uptake and DNA binding of the novel trinuclear platinun complex BBR 3464 in sensitive and cisplatin resistant murine leukemia cells.. PubMed. 18(4C). 3113–7. 51 indexed citations
10.
Palumbo, Manlio, Claudia Sissi, Nives Carenini, et al.. (1997). Physicochemical properties, cytotoxic activity and topoisomerase ii inhibition of 2,3-diaza-anthracenediones. Biochemical Pharmacology. 53(2). 161–169. 14 indexed citations
11.
MENTA, E., Roberto Di Domenico, C. Manzotti, et al.. (1997). Chemical and biological properties of a novel bifunctional triplatinum phase I clinical agent. Journal of Inorganic Biochemistry. 67(1-4). 173–173. 4 indexed citations
12.
Krapcho, A. Paul & E. MENTA. (1997). Antitumor aza-anthrapyrazoles. Drugs of the Future. 22(6). 641–641. 16 indexed citations
13.
Antonini, Ippolito, Paolo Polucci, Maria M. Bontemps‐Gracz, et al.. (1996). Pyrimido [4,5,6-kl] acridines, a new class of potential anticancer agents. Synthesis and biological evaluation.. PubMed. 11(4). 339–49. 7 indexed citations
14.
Sissi, Claudia, Giovanni Capranico, E. MENTA, & Manlio Palumbo. (1996). Aza-bioisosteres of 9, 10-anthracenedione: a modulation of DNA sequence specificity.. Molecular Pharmacology. 50(4). 838–845. 5 indexed citations
15.
Palumbo, Manlio, Claudia Sissi, Giovanni Capranico, et al.. (1995). Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.. Molecular Pharmacology. 48(1). 30–38. 53 indexed citations
16.
Krapcho, A. Paul, Miles P. Hacker, E. MENTA, et al.. (1995). Aza and diaza bioisosteric anthracene-9,10-diones as antitumor agents.. Acta Biochimica Polonica. 42(4). 427–432. 11 indexed citations
17.
18.
Krapcho, A. Paul, Johanna Polsenberg, Miles P. Hacker, et al.. (1993). The synthesis of 6,9‐difluorobenzo[g]quinoline‐5,10‐dione. Displacements of the fluorides by diamines which lead to 6,9‐bis[(aminoalkyl)amino]benzo[g]quinoline‐5,10‐diones. Journal of Heterocyclic Chemistry. 30(6). 1565–1569. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gino Beggiolin Breakdown of academic impact, for papers by Homayon J. Arabshahi Breakdown of academic impact, for papers by S Tognella Breakdown of academic impact, for papers by Roberto Di Domenico Breakdown of academic impact, for papers by Wei-Guo Bao Breakdown of academic impact, for papers by Tsung‐Chih Chen Breakdown of academic impact, for papers by Amalia Cipollone Breakdown of academic impact, for papers by Petr Sova Breakdown of academic impact, for papers by Dan Berger Breakdown of academic impact, for papers by Elin Jerremalm
Rankless by CCL
2026